Compare MDXG & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXG | SSII |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | MDXG | SSII |
|---|---|---|
| Price | $5.16 | $3.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.67 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 112.0K |
| Earning Date | 02-25-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $393,442,000.00 | $36,066,457.00 |
| Revenue This Year | $19.13 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.07 | ★ N/A |
| Revenue Growth | 14.77 | ★ 158.36 |
| 52 Week Low | $4.89 | $3.02 |
| 52 Week High | $8.65 | $22.42 |
| Indicator | MDXG | SSII |
|---|---|---|
| Relative Strength Index (RSI) | 29.11 | 29.30 |
| Support Level | $4.89 | $3.40 |
| Resistance Level | $5.21 | $6.01 |
| Average True Range (ATR) | 0.17 | 0.52 |
| MACD | 0.02 | -0.15 |
| Stochastic Oscillator | 34.82 | 11.46 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.